ArticleTranslational cancer research2024

Clinical and pathological characteristics of HR+ breast cancer with HER2 low and HER2(0) expression: exploring endocrine therapy sensitivity.

Xin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.